MMP2 and cardiovascular disorder: The Letourneur's group reported that implantation of stents coated with siRNA targeting MMP-2 which is associated with restenosis can induce an uptake of siRNA into the arterial wall and decrease pro-MMP2 activity [47], suggesting that stents coated with siRNA represent as a therapeutic approach for cardiovascular diseases.